Speaker illustration

Doctor Maria Ferre-Vallverdu

St Vincent's University Hospital, Dublin (Ireland)

Member of:

Heart Failure Association

High prevalence of progression of structural and functional abnormalities in a cohort at -risk for heart failure. Report from the STOP HF cohort.

Event: Heart Failure 2019

Topic: Prevention

Session: Rapid Fire 7 - Improving our insights: biomarkers, imaging, scores


Careful volume assessment appears to be the critical factor in achieving clinical trial dose of sacubitril/valsartan in the community.

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb